Literature DB >> 12519396

Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.

S Resino1, M L Abad, J Navarro, J M Bellón, S Sánchez-Ramón, M Angeles Muñoz-Fernández.   

Abstract

The objective of the study was to investigate the relationship between various CD4+ T cell subsets and the ability of peripheral blood mononuclear cells (PBMC) to proliferate to several stimuli in vertically human immunodeficiency virus type 1 (HIV-1)-infected children. We studied 29 HIV-1-infected children on highly active antiretroviral therapy (HAART) (median duration: 12.3 months). T cell subsets were determined by flow cytometry. Plasma viral load (VL) was quantified using a standardized molecular method. Proliferative responses were evaluated by [3H]-thymidine incorporation. Decreased proliferative responses of PBMC to pokeweed mitogen (PWM) were found for HIV-1-infected children in Centers for Disease Control (CDC) clinical categories B and C when compared to the control group (P < 0.05). Similarly, children with < or = 15% CD4+ T cells showed a decrease in proliferative responses to PWM (P < 0.01), anti-CD3 + anti-CD28 (P < 0.01) and phytohaemagglutinin (PHA) (P < 0.05) with respect to the control group and to children with CD4+ T cells > or = 25%. Proliferative responses to PWM, anti-CD3+, anti-CD28 and PHA had a statistically significant positive correlation with CD3+/mm3, CD4+/mm3, % CD4 T cells, CD4/CD8 ratio and the percentage of naive T cell subsets (CD4+CD45RO-HLA-DR-, CD4+ CD45RA+ CD62L+, CD4+ CD45RA+), CD4+ CD62L+ and CD4+ T cells co-expressing CD38+ (CD4+ HLA-DR-CD38+, CD4+ CD38+). Moreover, we found a negative correlation between PBMC proliferative responses and % CD8 T cells, memory, memory-activated and activated CD4+ T cell subsets. Lower proliferative responses to PWM (P < 0.01) and PHA (P < 0.01) were associated with higher VL. Our data show that higher proliferative responses to PWM, anti-CD3 + anti-CD28 and PHA are associated with both non-activated and naive CD4+ T cell subsets in HIV-1-infected children on HAART.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519396      PMCID: PMC1808592          DOI: 10.1046/j.1365-2249.2003.02034.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.

Authors:  J Navarro; S Resino; J M Bellón; M L Abad; D Gurbindo; E Fernández-Cruz; M A Muñóz-Fernández
Journal:  AIDS Res Hum Retroviruses       Date:  2001-04-10       Impact factor: 2.205

2.  Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infections.

Authors:  A M van Rossum; H G Niesters; S P Geelen; H J Scherpbier; N G Hartwig; C M Weemaes; A J Veerman; M H Suur; E R de Graeff-Meeder; W A Slieker; W C Hop; A D Osterhaus; D M Burger; R De Groot
Journal:  J Pediatr       Date:  2000-06       Impact factor: 4.406

Review 3.  Molecular events mediating T cell activation.

Authors:  A Altman; K M Coggeshall; T Mustelin
Journal:  Adv Immunol       Date:  1990       Impact factor: 3.543

Review 4.  The synergy between naive and memory T cells during activation.

Authors:  A N Akbar; M Salmon; G Janossy
Journal:  Immunol Today       Date:  1991-06

5.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D R Lucey; C S Via; G M Shearer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation.

Authors:  D G Jackson; J I Bell
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

7.  Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents.

Authors:  T Böhler; J Walcher; G Hölzl-Wenig; M Geiss; B Buchholz; R Linde; K M Debatin
Journal:  AIDS       Date:  1999-05-07       Impact factor: 4.177

8.  Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.

Authors:  S Resino; J Navarro; J M Bellón; D Gurbindo; J A León; M A Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

9.  Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens.

Authors:  H Z Bass; P Nishanian; W D Hardy; R T Mitsuyasu; E Esmail; W Cumberland; J L Fahey
Journal:  Clin Immunol Immunopathol       Date:  1992-07

10.  Lymphocyte subsets in healthy children during the first 5 years of life.

Authors:  T Denny; R Yogev; R Gelman; C Skuza; J Oleske; E Chadwick; S C Cheng; E Connor
Journal:  JAMA       Date:  1992-03-18       Impact factor: 56.272

View more
  3 in total

1.  Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age.

Authors:  Jintanat Ananworanich; Tanakorn Apornpong; Pope Kosalaraksa; Tanyathip Jaimulwong; Rawiwan Hansudewechakul; Chitsanu Pancharoen; Torsak Bunupuradah; Mom Chandara; Thanyawee Puthanakit; Chaiwat Ngampiyasakul; Jurai Wongsawat; Suparat Kanjanavanit; Wicharn Luesomboon; Phennapha Klangsinsirikul; Nicole Ngo-Giang-Huong; Stephen J Kerr; Sasiwimol Ubolyam; Tawan Mengthaisong; Rebecca S Gelman; Kovit Pattanapanyasat; Vonthanak Saphonn; Kiat Ruxrungtham; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

2.  Value of a quality assessment program in optimizing cryopreservation of peripheral blood mononuclear cells in a multicenter study.

Authors:  Najib Aziz; Joseph B Margolick; Roger Detels; Charles R Rinaldo; John Phair; Beth D Jamieson; Anthony W Butch
Journal:  Clin Vaccine Immunol       Date:  2013-02-13

3.  Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.

Authors:  Ellen Van Gulck; Lotte Bracke; Leo Heyndrickx; Sandra Coppens; Derek Atkinson; Céline Merlin; Alexander Pasternak; Eric Florence; Guido Vanham
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.